Abbott has secured the US Food and Drug Administration (FDA) approval for its next-generation CardioMEMS HERO device, which is designed to support remote heart failure monitoring. The new pulmonary ...

Abbott Laboratories recently received FDA approval for its redesigned CardioMEMS Hero remote heart failure monitoring system, featuring a smaller, lighter reader aimed at improving patient convenience ...

CardioMEMS ran into a regulatory roadblock last week, when an FDA advisory panel recommended that the agency not approve the company's Champion HF Monitoring System. The device is said to be the first ...

December 8, 2011 (Gaithersburg, Maryland) — An FDA advisory panel collectively decided a tiny pulmonary-artery (PA) pressure monitor for patients with heart failure (HF) isn't ready for prime time.

PRESS RELEASE: St. Jude Medical, Inc. a global medical device company, and privately-held CardioMEMS today announced that they have reached an agreement under which St. Jude Medical will make a $60 ...

Abbott’s CardioMEMS™ HERO is a compact remote reader that is 60% lighter compared to its previous generation device for heart failure patients with Abbott’s CardioMEMS pulmonary artery pressure sensor ...

WASHINGTON (Reuters) - A Food and Drug Administration review of CardioMEMS' device for treating heart failure found it has met its main safety and effectiveness goals, based on trial results. But the ...

Add Yahoo as a preferred source to see more of our stories on Google. Abbott's CardioMEMS cardiac sensor will now be available to patients with chronic heart failure through the NHS. Image credit: ...

Oak Ridge, TN, March 23, 2023 (GLOBE NEWSWIRE) -- Daxor Corporation (DXR) (NYSE: DXR), the global leader in blood volume measurement technology, today announces new data validating the benefits of the ...

WASHINGTON, Dec 5 (Reuters) - U.S. health regulators on Monday said a CardioMEMs implant for treating heart failure met its main safety and effectiveness targets but warned of potential bias in the ...